Centivax, a leader in universal vaccine development, is working to eliminate the threat of seasonal and pandemic influenza through its universal flu vaccine, Centi-Flu. Notably, animals immunized with Centi-Flu produced broad neutralizing titers and robust cellular immunity that spans over a century’s worth of influenza strains, including those not in the vaccine itself—including neutralizing antibody titers and T-cell responses against the currently circulating H5N1 pandemic strain. Centivax’s goal is to protect people of all ages and regions from influenza, end the pandemic era, and ultimately usher in a world free from the burden of flu.